Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2010
11/03/2010EP2245017A2 Novel heterocycles
11/03/2010EP2245012A1 Inhibitors of p38 map kinase
11/03/2010EP1831179B1 Method for the production of onium salts with tetrafluoroborate anion having a reduced halide content
11/03/2010EP1745002B1 Novel compounds, their preparation and use
11/03/2010EP1496838B1 Substituted amides
11/03/2010CN1615295B Compounds for treatment of inflammation, diabetes and related disorders
11/03/2010CN101875666A Optical pure 1,3-alkamine compound as well as preparation method and application thereof in preparing Dapoxetine and analogues thereof
11/03/2010CN101875654A Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
11/03/2010CN101875643A Pyridine or thiazole-contained arylmethyl ureide compound as well as preparation method and application thereof
11/03/2010CN101875632A Pyridinethione salt and preparation method thereof
11/03/2010CN101875631A Dye composition
11/03/2010CN101875630A Preparation method of pyridine-2,3-dicarboxylic ester
11/03/2010CN101875629A Industrial preparation method of pantoprazole intermediate pyridine hydrochloride
11/03/2010CN101875628A Preparation method of paraquat chloride
11/03/2010CN101875617A Carbamyl aromatic acid compound with alkoxy replacing aromatic ring, preparation method and application thereof
11/03/2010CN101875590A Method for synthesizing acrylamide compound
11/03/2010CN101874801A Application of pyridine compounds in preparing medicaments for treating diabetic nephropathy
11/03/2010CN101874800A Medicament for treating chronic interstitial nephritis
11/03/2010CN101874798A Difunctional inhibitor of leukotriene A4 hydrolase and cyclooxygenase and application thereof
11/02/2010US7825279 Fused ring dicationic anti-protozoan agents and their prodrugs
11/02/2010US7825255 Adenosine receptor selective modulators
11/02/2010US7825238 Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
11/02/2010US7825133 a mixture of 1-(4-hydroxyphenyl)-5-methylpyridin-2-one and pharmaceutically-acceptable excipients, used foro the treatment of liver fibrosis
11/02/2010US7825069 Normalization; aggregation; mass spectrometry
11/02/2010CA2460144C Pyridinic sulfonamide derivatives, method of production and use thereof
11/02/2010CA2400167C Insecticidal anthranilamides
11/02/2010CA2389681C Npy y5 antagonist
11/02/2010CA2311456C Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/2010
10/28/2010WO2010123153A1 Novel organic compound, light-emitting device, and image display apparatus
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010123131A1 Metal complex having aromatic ligand that contains nitrogen atom
10/28/2010WO2010123049A1 Selective ep4 receptor agonistic substance for treatment of cancer
10/28/2010WO2010122980A1 Novel thyroid hormone β receptor agonist
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2010122082A1 Heterocyclic antiviral compounds
10/28/2010WO2010093889A3 Solid forms of 2-(2, 4-difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide
10/28/2010WO2010093849A3 Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions
10/28/2010WO2010035283A3 Novel compounds for producing substituted sulfoxides, process for producing the same and use thereof
10/28/2010WO2009127338A8 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
10/28/2010US20100274051 Inflammatory cytokine release inhibitor
10/28/2010US20100274022 G protein-coupled receptor inhibitor and pharmaceutical product
10/28/2010US20100274021 Method for producing 2,2-difluoroethylamine derivatives by imine hydrogenation
10/28/2010US20100274006 Clathrate compound, method for controlling concentration of aqueous agricultural chemical active ingredient solution, and agricultural chemical formulation
10/28/2010US20100273919 Twisted pi-electron system chromophore compounds with very large molecular hyperpolarizabilities and related compositions and devices
10/28/2010US20100273883 Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
10/28/2010US20100273836 Oxime ether derivative and fungicide for agricultural and horticultural use
10/28/2010US20100273835 Novel compounds
10/28/2010US20100273828 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
10/28/2010US20100273801 Betulin derived compounds useful as antibacterial agents
10/28/2010US20100273739 Aminotetraline Derivatives, Pharmaceutical Composition, Containing Them, and Their Use in Therapy
10/28/2010US20100272726 Assays, methods and means
10/28/2010US20100272677 Heterocyclic antiviral compounds
10/28/2010US20100272656 Flavor Molecules
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/28/2010CA2758894A1 Novel thyroid hormone .beta. receptor agonist
10/28/2010CA2758838A1 Heterocyclic antiviral compounds
10/28/2010CA2754702A1 Selective ep4 receptor agonistic substance for treatment of cancer
10/27/2010EP2243766A2 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
10/27/2010EP2243761A1 Phenanthrene derivatives, light-emitting device and image display apparatus using the same
10/27/2010EP2242742A2 Organic compounds
10/27/2010EP2242741A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof
10/27/2010EP1789044B1 Phenylaminopyridines and phenylaminopyrazines
10/27/2010CN1585640B N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
10/27/2010CN1585633B Phenethanolamine derivatives for treatment of respiratory diseases
10/27/2010CN101870705A Novel organic compound, light-emitting device, and image display apparatus
10/27/2010CN101870703A Linked disulfide propyl porphyrin and metal complex, preparation method and application thereof
10/27/2010CN101870673A Dye compound
10/27/2010CN101213176B Improved process for the preparation of 3,5-diethyl-1,2-dihydro-1-phenyl-2-propylpyridine
10/26/2010US7820846 by phosgenation of an aminobenzoylsulfamic acid amide intermediate; prepared from a p-nitrobenzoyl chloride or benzoate and a sulfamic acid amide and reducing the nitrobenzoylsulfamic acid amide; isocyanates are crop protection agents
10/26/2010US7820827 3,4-disubstituted-4-aryl-piperidine; treating pain with opioids while avoiding side effects such as constipation, nausea and vomiting by administering said compounds; treating gastrointestinal disorders such as ileus (bowel obstruction)
10/26/2010US7820817 substituted piperazine compounds that are useful modulators of muscarinic receptors; 1-(5-bicyclo[2.2.1]hept-2-enylmethyl)-4-(3-nitro-2-pyridyl)-piperazine; treatment of COPD, asthma, urinary incontinence, glaucoma, Alzheimer's (AchE inhibitors), and pain
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010US7820700 2-phenylpyridine derivative
10/26/2010US7820698 3,5-dichloro-pyridin-4-ylmethyl)-(3,4-dimethoxy-phenyl)-(4-fluoro-benzyl)-amine; treating diseases involving inflammation, such as asthma or arthritis, or diseases of the central nervous such as cognitive decline or memory loss
10/26/2010US7820696 Compounds and methods for controlling fungi, bacteria and insects
10/26/2010US7820641 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy
10/26/2010CA2565813C Substituted methyl aryl or heteroaryl amide compounds
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2412164C Amidine derivatives as selective antagonists of nmda receptors
10/26/2010CA2410594C Heterocyclic aminoalkylpyridine derivatives as psychopharmaceuticals
10/26/2010CA2353627C Picolinamide derivative and harmful organism control agent comprising said picolinamide derivative as active component
10/21/2010WO2010119992A1 Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
10/21/2010WO2010119914A1 Novel fused polycyclic compound and organic light emitting device
10/21/2010WO2010119886A1 Method for producing 2-halogeno-6-substituted-4-trifluoromethylpyridine
10/21/2010WO2010089773A3 Process for preparation of nitropyridine derivatives
10/21/2010WO2009118516A8 Process for the preparation of donepezil hydrochloride
10/21/2010US20100267946 Prodrugs of gaba analogs, compositions and uses thereof
10/21/2010US20100267945 Amine derivative having npy y5 receptor antagonistic activity
10/21/2010US20100267780 Bicyclic aryl and heteroaryl receptor modulators
10/21/2010US20100267779 Novel Compounds and Methods of Using Them
10/21/2010US20100267778 Diphenyl ether compound, process for producing the same, and use
10/21/2010US20100267774 P38 map kinase inhibitors
10/21/2010US20100267739 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
10/21/2010US20100267738 Novel amide and amidine derivatives and uses thereof
10/21/2010US20100267716 Methods of treating inflammations and infections with pyridinium salts
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010US20100267704 Autophagy Inducing Compounds and Uses Thereof in Treating Autophagy Associated Diseases
10/21/2010US20100267697 Ion channel modulators
10/21/2010US20100267676 Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/21/2010US20100267609 Compounds which inhibit beta-secretase activity and methods of use thereof